Search results for "Concentration."

showing 10 items of 1849 documents

The effect of different periods of argon deaeration on exhaled breath condensate pH.

2011

Exhaled breath condensate (EBC) pH has been considered as a biomarker of airway inflammation in asthma. However, little information is available on the duration of argon deaeration required to achieve a stable pH in EBC samples.To identify differences in EBC pH after argon deaeration for 2, 4, and 8 min.EBC pH was determined in EBC samples from 48 subjects with allergic rhinitis (11 asthmatics) and 14 healthy volunteers without deaeration and after argon deaeration for 2, 4, and 8 min.The mean (95% CI) pH values obtained from samples analyzed after 4 min [7.66 (7.52-7.80)] and 8 min [7.70 (7.55-7.85)] of argon deaeration were significantly less acidic (p.001) than those identified after 2 m…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyGastroenterologyMean differenceDrug Administration ScheduleInternal medicineHealthy volunteersmedicineHypersensitivityImmunology and AllergyHumansExhaled breath condensateArgonAsthmaRhinitisbusiness.industryAirway inflammationHydrogen-Ion Concentrationmedicine.diseaseBreath TestsAnesthesiaPediatrics Perinatology and Child HealthBiomarker (medicine)FemalebusinessBiomarkersThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Evaluation of gastric intramucosal pH during and after pediatric cardiac surgery.

1997

Objectives: In adult patients, intramucosal pH (pHi) has been advocated to detect postoperative complications. The purpose of our study was to evaluate this technique in pediatric patients during and after cardiac surgery. Methods: Thirty-five infants (age: 5 days to 15 years, median 1.8 years; and weight: 3.2‐32 kg, median 9.8 kg) were studied. pHi was measured before cardiopulmonary bypass (CPB), after 30 min of CPB, prior to weaning off CPB, at intensive care unit arrival, and 6, 12, 24, 48 and 72 h after surgery. Results: There were no complications related to the tonometer. A pathologically low pHiB 7.32 was found during surgery in less than 17%, at intensive care unit arrival in 83% a…

Pulmonary and Respiratory MedicineHeart Defects CongenitalMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentSensitivity and Specificitylaw.inventionFontan procedurePostoperative ComplicationslawIntensive Care Units NeonatalMonitoring IntraoperativemedicineCardiopulmonary bypassHumansChildSurvival ratebusiness.industryStomachOrgan dysfunctionCentral venous pressureInfant NewbornInfantGeneral MedicineHydrogen-Ion ConcentrationIntensive care unitSurgeryCardiac surgerySurvival Ratemedicine.anatomical_structureGastric MucosaAnesthesiaChild PreschoolSurgeryFemalemedicine.symptomMorbidityCardiology and Cardiovascular MedicinebusinessEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

2012

The objective of this in-vitro study was to determine whether admixtures of the inhalation solutions Pulmozyme(®) (Dornase alfa) and either Bramitob(®) or Tobi(®) (both containing Tobramycin) are physicochemically compatible and to analyze the aerodynamic parameters of these admixtures. After mixing, test solutions were stored at room temperature and under ambient light conditions over a period of 24 h. Tobramycin concentrations were determined by using a fluorescence immunoassay. Stability of dornase alfa was determined by size-exclusion high performance liquid chromatography, ultraviolet spectroscopy, sodium dodecyl sulfate polyacrylamide gel electrophoresis and tentacle strong cation-exc…

Pulmonary and Respiratory MedicineTime FactorsDrug StorageHigh-performance liquid chromatographyDrug Incompatibilitychemistry.chemical_compoundDrug StabilityAdministration InhalationmedicineTobramycinGeometric standard deviationDeoxyribonuclease IPharmacology (medical)Sodium dodecyl sulfateParticle SizeAerosolsChromatographyInhalationNebulizers and VaporizersBiochemistry (medical)Osmolar ConcentrationDornase alfaHydrogen-Ion ConcentrationRecombinant ProteinsAnti-Bacterial AgentsDrug CombinationsPharmaceutical SolutionschemistryCompatibility (mechanics)TobramycinFeasibility StudiesParticle fractionmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Pathologies currently identified by exhaled biomarkers.

2013

Ancient Greek physicians already knew that the smell of human breath could provide a clue to the pathology. Nowadays, volatile breath biomarkers are known to be released in a broad range of diseases. However, their identification, isolation, and quantification as indicative of relevant alterations in clinical status have required the development of new techniques and analytical methods. Breath sample analysis encounters several obstacles. Particularly, there is a need of a system that could work in a continuous manner, with the low concentration and small volume of a sample. Herein we review, in the light of literature and our experience, clinical applications of the metal oxide semiconduct…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyVolatile Organic CompoundsIsolation (health care)Physiologybusiness.industrySmall volumeGeneral NeuroscienceDiseasemedicine.diseaseOxide semiconductorBreath gas analysisBreath TestsMedicineHumansbusinessIntensive care medicineMultiple chemical sensitivityVolume concentrationBiomarkersRespiratory physiologyneurobiology
researchProduct

Fate of pulp mill effluent compounds in a finnish watercourse

2013

Chloroorganic chemicals emitted from the pulp and paper mill at nekoski in central Finland were monitored for several years. Concentration time series are used for evaluating the environmental fate and the applicability and validity of an exposure models. Fitted elimination rates of 3,4,5-Tri-, 4,5,6-Tri-, Tetrachloroguaiacol and 2,4,6-Trichlorophenol are approx. 0.22 d(-1), or rather the half-lives are approx. 3 days. The elimination is most likely by biodegradation and transport-controlled. For 2,3,6-trichloro-p-cymene, fate simulations indicate significant volatilization and sedimentation. Good agreement is achieved with a one-dimensional steady-state box model, except for concentrations…

Pulp millVolatilisationbusiness.industryHealth Toxicology and MutagenesisPulp (paper)Environmental engineeringBioconcentrationPaper millGeneral MedicineBiodegradationengineering.materialPulp and paper industryPollutionengineeringEnvironmental ChemistryEcotoxicologyEnvironmental sciencebusinessEffluentEnvironmental Science and Pollution Research
researchProduct

Robustness of the Gaussian concentration inequality and the Brunn–Minkowski inequality

2016

We provide a sharp quantitative version of the Gaussian concentration inequality: for every $r>0$, the difference between the measure of the $r$-enlargement of a given set and the $r$-enlargement of a half-space controls the square of the measure of the symmetric difference between the set and a suitable half-space. We also prove a similar estimate in the Euclidean setting for the enlargement with a general convex set. This is equivalent to the stability of the Brunn-Minkowski inequality for the Minkowski sum between a convex set and a generic one.

Pure mathematicsGaussianConvex setkvantitatiivinen tutkimus01 natural sciencesMeasure (mathematics)Square (algebra)010104 statistics & probabilitysymbols.namesakeMathematics - Analysis of PDEsQuantitative Isoperimetric InequalitiesFOS: MathematicsMathematics::Metric Geometry0101 mathematicsConcentration inequalitySymmetric differenceMathematicsmatematiikkaApplied MathematicsProbability (math.PR)010102 general mathematicsMinkowski inequalityMinkowski additionBrunn–Minkowski inequalityGaussian concentration inequalitysymbols49Q20 52A40 60E15Mathematics - ProbabilityAnalysisAnalysis of PDEs (math.AP)Calculus of Variations and Partial Differential Equations
researchProduct

Synthesis and Biological Evaluation of 2-Amino-3-(3’,4’,5’-Trimethoxybenzoyl)-6-Substituted-4,5,6,7-Tetrahydrothieno[2,3-c]pyridine Derivatives as An…

2008

Microtubules are among the most successful targets of compounds potentially useful for cancer therapy. A new series of inhibitors of tubulin polymerization based on the 2-amino-3-(3,4,5-trimethoxybenzoyl)-4,5,6,7-tetrahydrothieno[b]pyridine molecular skeleton was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization, and cell cycle effects. The most promising compound in this series was 2-amino-3-(3,4,5-trimethoxybenzoyl)-6-methoxycarbonyl-4,5,6,7-tetrahydrothieno[b]pyridine, which inhibits cancer cell growth with IC(50)-values ranging from 25 to 90 nM against a panel of four cancer cell lines, and interacts strongly with tubulin by binding to the co…

PyridinesStereochemistryClinical BiochemistryPharmaceutical ScienceAntimitotic AgentsCrystallography X-RayBiochemistryChemical synthesisArticleInhibitory Concentration 50Structure-Activity Relationshipchemistry.chemical_compoundTubulinMicrotubuleDrug DiscoveryPyridineAnimalsStructure–activity relationshipCytotoxicityMolecular BiologyMolecular StructurebiologyBicyclic moleculeChemistryOrganic ChemistryTubulinbiology.proteinMolecular MedicineAntimitotic Agent
researchProduct

Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[2E]-3-phenylprop-2-enoylamino}benzamides

2011

Several new 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides 12a–s and 17t–v were synthesized by stirring in pyridine the (E)-3-(2-R1-3-R2-4-R3-phenyl)acrylic acid chlorides 11c–k and 11t–v with the appropriate anthranilamide derivatives 10a–c or the 5-iodoanthranilic acid 13. Some of the synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). COMPARE analysis, effects on tubulin polymerization in cells and with purified tubulin, and effects on cell cycle distribution for 17t, the mo…

Pyridinesmedicine.drug_classStereochemistryAntineoplastic AgentsCarboxamideChemical synthesisArticlePolymerizationInhibitory Concentration 50Structure-Activity RelationshipTubulinCell Line TumorDrug DiscoverymedicineHumansStructure–activity relationshiportho-AminobenzoatesCytotoxicity2-{[2E]-3-phenylprop-2-enoylamino}benzamides antimitotic agents cytotoxic activityPharmacologyDose-Response Relationship DrugbiologyChemistryTubulin ModulatorsCell CycleOrganic ChemistryGeneral MedicineCell cycleSettore CHIM/08 - Chimica FarmaceuticaTubulin ModulatorsTubulinAcrylatesMechanism of actionBiochemistryBenzamidesbiology.proteinDrug Screening Assays Antitumormedicine.symptom
researchProduct

High-performance micellar liquid chromatography determination of sulphonamides in pharmaceuticals after azodye precolumn derivatization

1995

Abstract A chromatographic procedure with precolumn derivatization to form the N-(1-naphthyl)ethylenediamine dihydrochloride azodyes is proposed for the analysis of several sulphonamides (sodium sulphacetamide, sulphadiazine, sulphaguanidine, sulphamerazine, sulphamethizole, sulphamethoxazole, sulphanilamide and sulphathiazole) in pharmaceutical preparations (tablets, pills, capsules, suspensions and drops). The separation is performed with a 0.05 M sodium dodecyl sulphate/2.4% pentanol eluent at pH 7. The precolumn derivatization improved the resolution in the chromatograms and increased the selectivity in the determination of mixtures of sulphonamides and in preparations where other drugs…

Quality ControlSulfonamidesChromatographyChemistrySodiumClinical BiochemistryPharmaceutical Sciencechemistry.chemical_elementHydrogen-Ion ConcentrationHigh-performance liquid chromatographyDosage formAnalytical Chemistrychemistry.chemical_compoundColumn chromatographyMicellar liquid chromatographyDrug DiscoveryIndicators and ReagentsSpectrophotometry UltravioletDerivatizationAzo CompoundsQuantitative analysis (chemistry)Chromatography High Pressure LiquidMicellesSpectroscopyAntibacterial agentJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Analysis of Urine Samples Containing Cardiovascular Drugs by Micellar Liquid Chromatography with Fluorimetric Detection

1999

A simple direct injection chromatographic procedure with fluorimetric detection is successfully applied to the determination of mixtures of 4 diuretics (amiloride, bendroflumethiazide, piretanide, and triamterene) and 6 beta-blockers (acebutolol, atenolol, labetalol, metoprolol, nadolol, and propranolol), which are usually administered in combinations for the treatment of hypertension, in urine samples. The procedure makes use of C18 columns and micellar mobile phases of sodium dodecyl sulphate (SDS), propanol, and phosphate buffer at pH 3. The adequate resolution of most drugs is obtained with a chemometrics approach where the retention is modeled as a first step using the retention factor…

Quality Controlmedicine.medical_treatmentAdrenergic beta-AntagonistsMicellar electrokinetic chromatographyAnalytical ChemistryPropanolSurface-Active Agentschemistry.chemical_compoundmedicineHumansFluorometryBendroflumethiazideDiureticsAntihypertensive AgentsMicellesTriamtereneChromatographyChemistryElutionPiretanideGeneral MedicineHydrogen-Ion ConcentrationMicellar liquid chromatographyIndicators and ReagentsDiureticMathematicsChromatography Liquidmedicine.drugJournal of Chromatographic Science
researchProduct